Top Markets
#1 MowCat MowCat +48.93%
#2 Velvet Velvet +23.57%
#3 Derive Derive +20.28%
#4 Quack AI Quack AI +20.19%
#5 Bermuda Shorts Bermuda Shorts +15.80%
#6 MarsCoin MarsCoin +15.17%
#7 Geodnet Geodnet +14.36%
#8 Audiera Audiera +13.55%
#9 Cross Cross +13.10%
#10 aPriori aPriori +12.66%
Coin of the day
MowCat MowCat
Instellingen
Taal
DUTCH
Valuta
USD
Thema
MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

MyMD Pharmaceuticals, Inc.

MYMD
Rang in aandelen #35400
MyMD Pharmaceuticals, Inc. is a pharmaceutical firm currently in the clinical... MyMD Pharmaceuticals, Inc. is a pharmaceutical firm currently in the clinical development stage, focused on devising diverse therapeutic strategies that target the underlying origins of various illnesses. One of its key initiatives is the development of MYMD-1, a drug platform centered on a small molecule presently undergoing clinical trials. This molecule works by regulating the immune system to suppress TNF-alpha, a major contributor to chronic inflammation, along with other pro-inflammatory cell-signaling proteins. MYMD-1 is being explored for its potential to delay aging, extend lifespan, manage autoimmune conditions, and treat depression linked to COVID-19. Furthermore, the company is advancing Supera-CBD, a synthetic version of cannabidiol, which aims to address chronic pain, addiction, and epilepsy. MyMD Pharmaceuticals was established in 2014 and its corporate headquarters are situated in Baltimore, Maryland.
Aandeelprijs
$1.85
Laatst gesynchroniseerd: 2024-08-19
Marktkapitalisatie
$3.96M
Verandering (1 dag)
2.78%
Verandering (1 jaar)
0.00%
Land
US
Handel MyMD Pharmaceuticals, Inc. (MYMD)

Categorie

Healthcare
Aandelsplitsingen voor MyMD Pharmaceuticals, Inc. (MYMD)
Het aandeel MyMD Pharmaceuticals, Inc. (symbool: MYMD) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 16, 2026.
Eén aandeel MYMD dat vóór Aug 16, 2026 werd gekocht, staat nu gelijk aan 0 aandelen MYMD.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE